1 of 1
Story summary
- Utah launched a pilot program that lets artificial intelligence renew certain medical prescriptions without human involvement, with Doctronic.
- The program will initially handle 190 medications, with human doctors reviewing the first 250 prescriptions in each class.
- Proponents say the AI approach could lower costs and improve access, while concerns include misuse and missed clinical details.
- The U.S. Food and Drug Administration's stance on this AI application remains unclear, complicating expansion.
